Download Curriculum Vitae

Hung S. Luu, PharmD, MD, FCAP is the Director of Clinical Pathology at Children’s Health. He is Associate Professor of Pathology at UT Southwestern Medical Center. As part of the faculty on the hematopathology service at the University of Texas Medical Center in Dallas Texas, he participates in the training of pathology residents and fellows in the examination of bone marrows, lymphoid tissue and body fluid to diagnose hematolymphoid malignancies.

Dr. Luu received his pathology residency training at Cedars-Sinai Medical Center in Los Angeles, California, and completed a fellowship in hematopathology at City of Hope in Duarte, California. He has board certification in anatomic and clinical pathology, hematopathology, and clinical informatics. His research interests include hematologic malignancies in the pediatric population, hematology with an emphasis in hemoglobinopathies, and utilizing technology and process improvement in the laboratory to improve operational efficiency and clinical outcomes.

Dr. Luu is an active member of the College of American Pathologist and serves on the Clinical Informatics Committee. He serves as the co-chair of the implementation committee for the Food and Drug Administration’s SHIELD initiative, a multi-stakeholder initiative to improve the quality, interoperability, and portability of laboratory data. Dr. Luu was appointed to a three-year term on the Health Information Technology Advisory Council (HITAC) in 2022 and was also appointed to the Clinical Laboratory Improvement Advisory Committee (CLIAC) in 2023.


Medical School
Oregon Health and Science University (2004)
University of Oregon Health Sciences Center - GME (2005), General Surgery
Cedars-Sinai Medical Center (2009), Anatomic & Clinical Pathology
City of Hope National Medical Center (2010), Hematopathology

Research Interest

  • Clinical Informatics
  • Coagulation
  • Hematolymphoid Neoplasms
  • Hemoglobinopathies
  • Myeloid Neoplasms
  • Process Improvement


Featured Publications LegendFeatured Publications

Digital pathology and artificial intelligence as the next chapter in diagnostic hematopathology.
Lin E, Fuda F, Luu HS, Cox AM, Fang F, Feng J, Chen M, Semin Diagn Pathol 2023 Feb
Adult mixed phenotype acute leukemia (MPAL): B/myeloid MPALisoMPO is distinct from other MPAL subtypes.
Weinberg OK, Dennis J, Zia H, Chen P, Chu A, Koduru P, Luu HS, Fuda F, Chen W, Int J Lab Hematol 2022 Nov
A t(11;14)(q13;q32)/CCND1::IGH carrying progenitor germinal B-cell with subsequent cytogenetic aberrations contributes to the development of classic Hodgkin lymphoma.
García R, Timmons C, Luu H, Miller V, Fuda F, Chen W, Koduru P, Cancer Genet 2022 Oct 268-269 97-102
Hematologic Complications in Patients Hospitalized with COVID-19 Infection.
Lin E, Araj E, Markantonis J, Luu H, Chen M, Hematol Rep 2022 Jul 14 3 228-234
A Combined Biomarker of Bright CD38 and MYC =55% Is Highly Predictive of Double-/Triple-Hit High-Grade B-Cell Lymphoma.
Alsuwaidan A, Koduru P, Fuda F, Manuel Jaso J, Chen M, Rosado F, Luu HS, Sweed N, Garcia R, Doucet M, Desai NB, Kumar KA, Awan FT, Ramakrishnan Geethakumari P, Chen W, Am J Clin Pathol 2022 May
Chromosomal microarray reinterpretation: Applications to pediatric practice.
Shi G, Xu J, Barnes SF, Farooqi MS, Luu HS, Gotway G, Park JY, J Pediatr 2021 Dec


Featured Books Legend Featured Books

Honors & Awards

  • College of American Pathologists President's Honors Award
  • American Association of Clinical Chemistry Outstanding Speaker Award
  • Southwestern Association of Microbiology 32nd Annual Meeting Poster Award

Professional Associations/Affiliations

  • American Society for Clinical Pathology (2010)
  • College of American Pathologists (2010)
  • American Society of Hematology (2009)
  • United States and Canadian Academy of Pathology (2005)